Taking stock of the drug industry, from the lab to the medicine chest

August 27, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe Third Rock tops STAT's VC rankings, boosted by early biotech investments STAT's sixth annual "Ranking Biotech's Top Venture Capital Firms" report has Third Rock Ventures at No. 1, returning $3.58 for every $1 invested. By Allison DeAngelis FDA issues narrower approvals for Covid boosters, revokes emergency authorizations FDA ends emergency Covid vaccine authorizations, limiting shots for healthy children under 5 while approving boosters for older and high-risk groups. By Lizzy Lawrence and Matthew Herper STAT+ | The most burdensome diseases globally are the least studied, but the gap is narrowing Diseases that cause the most harm are often the least-researched. While that is changing, research cuts threaten that progress, study says. By Anil Oza

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser